$8.32
+0.74 (+9.76%)
Open$7.63
Previous Close$7.58
Day High$9.16
Day Low$7.63
52W High$15.30
52W Low$5.29
Volume—
Avg Volume6.7K
Market Cap1.20B
P/E Ratio315.89
EPS$0.19
SectorN/A
Analyst Ratings
Strong Buy
9 analysts
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 298.44M | 264.43M | 276.45M |
| Net Income | 14.60M | 11.79M | 12.18M |
| Profit Margin | 4.9% | 4.5% | 4.4% |
| EBITDA | 27.42M | 22.09M | 25.58M |
| Free Cash Flow | 13.07M | 10.26M | 10.73M |
| Rev Growth | -8.4% | +2.2% | +6.3% |
| Debt/Equity | 0.81 | 0.83 | 0.74 |
N/A Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| EMAT | Evolution Metals & Technolog | $0.95 | -4.45% | — | 585.99M |
| PICS | Pics Nv | $7.39 | +6.18% | 4.1 | 961.54M |
| DMII | Drugs Made In America Acquis | $10.26 | +0.15% | 50.1 | 652.61M |
| CCCX | Churchill Capital Corp X-A | $10.08 | -5.62% | — | 2.32B |
| BEAG | Bold Eagle Acquisition Cor-A | $10.61 | +0.00% | 21.3 | 168.92M |
| CEPF | Cantor Equity Partners-Cl A | $10.33 | +0.00% | 41.5 | 590.36M |